Ordeniza, Juncris P.
HRN: 20-79-98 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/04/2024
01/11/2024
IV
54mg
Q8h
Septic Shock Sec To Infected Colostomy
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalMultiple Infections (tick All Sites) Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes